We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics - An LGC Company

Download Mobile App





Ultra-Fast COVID-19 PCR Test to Achieve High Accuracy at Speed 20 Times Faster than Lab-Based PCR Tests

By LabMedica International staff writers
Posted on 22 Nov 2021
Print article
Image: MolDx Analyzer (Photo courtesy of miDIAGNOSTICS)
Image: MolDx Analyzer (Photo courtesy of miDIAGNOSTICS)

An ultra-fast COVID-19 PCR test developed for point-of-care use combines the accuracy of central lab-based PCR testing with the speed of self-testing.

miDIAGNOSTICS (Leuven, Belgium) has developed a rapid COVID-19 PCR test that has the potential to achieve an excellent accuracy at a speed 20 times faster than ‘classic’ PCR machines in labs. The test, based on the company’s highly innovative diagnostics platform, involves the transfer of a nasopharyngeal swab sample on a PCR test card, from which the results are read by a compact reader.

The COVID-19 pandemic has underscored the importance of abundant and accurate diagnostics. It will still take quite some time before herd immunity will be achieved worldwide, and ongoing virus mutations and new variants pose major challenges to the vaccination process. Meanwhile, there is a great need for rapid accurate tests that can be performed at airports, in the workplace, at events, in doctors’ offices, or even at home. Unfortunately, rapid COVID-19 tests often have limited accuracy, while reliable diagnostic tests, based on PCR analysis and performed in central laboratories, can take anywhere from several hours to several days from a sample collection to a test result.

Enabled by miDIAGNOSTICS’ silicon chip technology, its ultra-fast PCR COVID-19 test combines the speed of a rapid antigen test with the performance of trusted PCR-based testing. The company’s ultra-fast COVID-19 PCR test will take 15 minutes from sample to result. Testing can be easily scaled up with the combination of multiple readers, because of the short turnaround time of 15 minutes, enabling simultaneous high throughput in many decentralized settings where highly accurate testing is desired, including at airports, offices, schools, events or any other local healthcare setting. Beyond COVID-19, the platform has the potential to be reconfigured for diagnosing other infectious diseases, as needed.

Related Links:
miDIAGNOSTICS 

New
Gold Supplier
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Microtome
M-250
New
Hepatitis B IgM ELISA
Anti-HBclgM
New
Automatic IFA Processor
AP 16 IF ELITE

Print article

Channels

Microbiology

view channel
Image: Trichinella sp. found in muscle tissue (Photo courtesy of McGill University)

Laboratory Features of Trichinellosis and Eosinophilia Threshold Determined

Trichinella nativa is a nematode worm, one of the species of the genus Trichinella, found in arctic and subarctic regions. It is highly pathogenic and has a high resistance to freezing. It is encapsulated,... Read more

Industry

view channel
Image: With Cell IDx’s acquisition, Leica Biosystems will be moving its multiplexing menu forward (Photo courtesy of Leica Biosystems)

Leica Biosystems Acquires Cell IDx, Expanding Offerings in Multiplexed Tissue Profiling

Leica Biosystems, a technology leader in automated staining and brightfield and fluorescent imaging (Nussloch, Germany), has acquired Cell IDx, Inc. (San Diego, CA, USA), which provides multiplex staining... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.